From Kazakhstan · Oncology
Cancer treatment in India for Kazakh patients
An oncology diagnosis compresses time. Between a biopsy result and the start of treatment there is often a window measured in weeks, and in that window Kazakh families increasingly ask whether India belongs in the comparison alongside the Turkish and Korean options everyone already knows. This page is about answering that question with documents rather than advertising: what pathology, imaging and reports a reviewing oncologist needs to give a considered view remotely, how a cancer quote gets built so that every drug, scan and radiation fraction is a visible line, and where the honest answers usually lie — including the possibility that treatment at home is the right call, or that most of your care belongs in Kazakhstan with one specific part of it handled in India.
We take no commissions from hospitals. Our fees are paid by you, published upfront, and itemized separately from your hospital bill. Full details on the Fees page.
Published fees, same from every country
- Remote consultation (teleconsult) $50
- Written independent second opinion $150
- Full journey coordination $1,000
Every fee is credited in full to the next step: the $50 consultation fee comes off the $150 second opinion, and the $150 second-opinion fee comes off the $1,000 full journey fee. You never pay twice for moving forward.
Start from the pathology, not from the summary
Oncology decisions rest on tissue. Before any opinion about a cancer plan, a reviewing oncologist wants the full histopathology report, the imaging with its radiologist's reports, and where possible the pathology slides or tissue block themselves, because a second reading of the original specimen is frequently the most informative step a family can take before choosing any destination. Add the letter from your oncologist in Kazakhstan naming the diagnosis, the stage and the plan proposed, plus a list of any chemotherapy cycles already completed. From those records, a $50 video consultation or a $150 written opinion can tell you whether the proposed protocol sits within accepted practice for your diagnosis, what it asks of you, and what should be clarified with your own team. Where the documents genuinely cannot carry an opinion, the specialist will say exactly that instead of improvising.
What India's depth is actually for
India's oncology case rests on high-acuity capability: advanced radiation platforms, cellular-therapy programmes and the systemic-therapy access that a large patient volume sustains, at costs that keep a self-funded course realistic. That case is real, but it is not universal. For many common cancers diagnosed at a routine stage, treatment available in Almaty or Astana is already reasonable, and Kazakhstan's oncology services have been developing steadily; a review will sometimes conclude that your plan at home is sound and that travelling adds risk and expense without changing the medicine. The purpose of an independent read is to put that judgement in front of you before money moves, not after. If one specific piece — a particular radiation course, a surgical reconstruction, a cellular-therapy programme — is the reason India is worth considering, the opinion should say so narrowly.
An oncology quote has to be drug by drug
A cancer bill has more moving lines than almost any other specialty: the systemic-therapy drugs and their cycles, radiation fractions, surgical fees, anaesthesia, imaging repeated during treatment, bed category, and the medicines you take home. A single-line package buries all of it, and it is exactly where inflated international quotes hide their margin. Every quote we obtain is itemized by the hospital itself, with each drug named and dosed on its own line and radiation priced per fraction, so if your protocol changes mid-course you can see which line moved and by how much. You pay the hospital directly on its own invoice at rates locked in writing before you travel; we never hold treatment money, and our facilitation fee is invoiced separately and never appears inside a hospital bill.
Funding: what we know and what we do not
We publish funding rails only where we have researched them, and for Kazakhstan we have not researched how public funding treats planned cancer treatment abroad — so we will not invent a scheme, a quota or a reimbursement figure here. If you hold private insurance or your employer provides coverage, check the policy documents directly with the insurer; whether it responds to treatment in India is their answer to give, not ours to guess. What we can do is make every number legible for whoever ends up paying: itemized hospital quotes, a published facilitation fee invoiced separately, and milestone receipts written to be forwarded into a family group chat. Families pooling money for a cancer journey tell us consistently that the itemized documents, not the destination brochure, are what made agreement possible.
Visa, flights and language
Kazakhstan is on India's official e-Visa eligibility list, so the e-Medical visa is applied for online, and companions can typically apply for linked e-Medical Attendant visas; confirm current terms on the official Indian portal when you apply, since they have moved before. We coordinate the hospital invitation letter the application needs. Almaty–Delhi flies nonstop daily as of mid-2026 in about three and a half hours, with a Mumbai–Almaty service several days a week; travellers from Astana connect through Almaty. Russian is the working bridge language: large hospitals' international desks keep Russian-speaking coordinators, reports are translated with the cost shown as its own line, and Kazakh-language interpretation is rare enough that we confirm what is actually available before you commit. Tripcuro plans travel around a confirmed admission date rather than around scarce seats.
Conditions we coordinate care for
- Breast cancer
- Lung cancer
- Colorectal and other gastrointestinal cancers
- Prostate, kidney and bladder cancers
- Cervical, ovarian and uterine cancers
- Head and neck cancers
- Lymphoma and leukemia
Procedures & services we coordinate
- Pathology and imaging review, biopsy and staging workup
- Cancer surgery, including minimally invasive and robot-assisted approaches where suitable
- Chemotherapy, targeted therapy and immunotherapy planning
- Radiation therapy (IMRT, IGRT, brachytherapy) coordination
- Bone marrow / stem cell transplant evaluation
- Tumor board review of complex cases
What to prepare
- The full histopathology report, and the pathology slides or tissue block if your lab will release them, since a second read is often the most valuable first step
- Imaging on disc or as files — CT, MRI or PET where performed — with the radiologist's reports attached
- The oncologist's letter naming the diagnosis, the stage and the plan proposed, including any protocol names
- A current medicine and dose list, plus the dates of any chemotherapy or radiation cycles already completed
- Recent counts and the kidney and liver values beside them — the readings that decide what a protocol can safely carry
- Insurance documents if you hold a policy, so we can say honestly what we do and do not know about it
- Passport validity and the name of the relative who will travel as attendant
Other specialties, same Kazakhstan process
Useful guides to read next
Oncology from Kazakhstan: FAQs
Can an oncologist really review my case without seeing me?
Is it worth having the pathology read a second time?
Will the state or an insurer in Kazakhstan pay for cancer treatment in India?
Why India rather than Turkey for cancer treatment?
How long would we need to stay in India?
Tell us about your case
A few lines are enough to start. We respond within four business hours.
Start from anywhere in Kazakhstan
Share your diagnosis and what has been advised in a few lines, on WhatsApp if that is easiest. A person reads it and comes back with honest next steps, including whether travelling is worth it at all.
We respond within four business hours.
We are a small team — on weekends, expect a reply within one business day.